Alnylam Pharmaceuticals
ALNY
#595
Rank
NZ$71.06 B
Marketcap
NZ$532.60
Share price
0.78%
Change (1 day)
33.91%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company